Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being key to wide rollout kdunleavy Fri, 10/29/2021 – 16:04 More: Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being
read moreSeagen stands by newly acquired HER2 breast cancer drug despite competition from AstraZeneca-Daiichi’s Enhertu kdunleavy Fri, 10/29/2021 – 15:38 More: Seagen stands by newly acquired HER2 breast cancer drug despite competition from AstraZeneca-Daiichi's Enhertu Source: fierce
read moreEven AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls JAK label aliu Fri, 10/29/2021 – 11:49 More: Even AbbVie CEO can't confirm Rinvoq's sales as FDA mulls JAK label Source: fierce
read moreAbbVie’s Vraylar turns in mixed results in depression, but pharma decides to file for approval anyway aliu Fri, 10/29/2021 – 10:23 More: AbbVie’s Vraylar turns in mixed results in depression, but pharma decides to file for approval anyway Source: fierce
read morePacira panel takes on uncomfortable women’s health topics to help women sharon.coey Fri, 10/29/2021 – 08:57 More: Pacira panel takes on uncomfortable women's health topics to help women Source: fierce
read moreThe companies will evaluate Trodelvy plus Keytruda for the first-line treatment of certain triple-negative breast cancer patients More: Gilead and MSD collab on Trodelvy/Keytruda breast cancer trial Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals